Source: BioPortfolio

Apexian Pharmaceuticals: Apexian Pharmaceuticals Dr. Mark Kelley Recognized as an Outstanding Researcher at Indiana UniversityPurdue University IUPUI

Apexian Pharmaceuticals a clinicalstage biotechnology company focused on developing safe and effective therapy for patients with high unmet medical needs is pleased to announce that its Chief Scientific Officer Mark Kelley PhD was r...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
David Broecker's photo - Interim-CEO of Apexian Pharmaceuticals

Interim-CEO

David Broecker

CEO Approval Rating

90/100

Read more